In an observational cohort study of 1127 cancer patients, AT-III was not associated with the risk of VTE; however, it showed a u-shaped association with the risk of all-cause mortality; patients with either very high or very low levels had worse OS [49]. This evidence concerns the gene SERPINC1 and cancer.